The unique value of breath biomarkers for estimating pharmacokinetic rate constants and body burden from environmental exposures

Breath Analysis for Clinical Diagnosis and Therapeutic Monitoring

Volumn , Issue , 2005, Pages 347-359

  Pleil, J D ^a,b   Kim, D ^b   Prah, J D ^c   Ashley, D L ^d   Rappaport, S M ^b  

^a U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

^b University of North Carolina at Chapel Hill   (United States)

^c U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

^d NATIONAL CENTER FOR ENVIRONMENTAL HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84967495570     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1142/9789812701954_0024     Document Type: Chapter

References (18)

1. USGS, Clawges R, Rowe R, Zogorski J. National Survey of MTBE and other VOCs in Community Drinking Water Sources. USGS FS-064-01, Oct 2001.
2. USGS, Personal communication: John S. Zogorsky, David A. Bender, VOC National Synthesis, U.S. Geological Survey, 2004.
3. EPA. Methyl Tertiary Butyl Ether, www.epa.gov/mtbe, 2001.
4. Prah J, Goldstein G, Devlin R, Otto D, Ashley D, House D, Willingham F, Cohen K, Gerrity T. Sensory, symptomatic, inflammatory, and ocular responses to and the metabolism of methyl tertiary butyl ether in a controlled human exposure. Inhalation Toxicology 1994; 6: 521-538.
5. McCarthy J, Tiernan M. MTBE in Gasoline: Clean Air and Drinking Water Issues. Congressional Research Service, The Library of Congress 2001: OC 98-290 ENR.
6. ATSDR, Agency for Toxic Substances and Disease Registry, www.atsdr.cdc.gov/toxprofiles/tp91.html, 1996.
7. Dekant W, Bernauer U, Rosner E, Amberg A. Toxicokinetics of ethers used as fuel oxygenates. Toxicology Letters 2001; 124: 37-45.
8. Prah J, Ashley D, Blount B, Case M, Leavens T, Pleil J, Cardinali F. Dermal, oral, and inhalation pharmacokinetics of methyl tertiary butyl ether (MTBE) in human volunteers. Toxicol Sci 2004; 77: 195-205.
9. Boroujerdi M. Pharmacokinetics: Principle and Applications. New York: Mc-Graw Hill, 2002.
10. Pleil J, Lindstrom A. Sample timing and mathematical considerations for modeling breath elimination of volatile organic compounds. Risk Analysis 1998; 18: 585-602.
11. Ashley DL, Bonin MA, Cardinali FL, McCraw JM, Holler JS, Needham LL, Patterson DG, Jr. Determining volatile organic compounds in human blood from a large sample population by using purge and trap gas chromatogra-phy/mass spectrometry. Anal Chem 1992; 64: 1021-1029.
12. Pleil J, Lindstrom A. Collection of a Single Alveolar Exhaled Breath for Volatile Organic Compounds Analysis. Journal of Industrial Medicine 1995; 28: 109-121.
13. Pleil J, Lindstrom A. Measurement of Volatile Organic Compounds in Exhaled Breath as Collected in SUMMA Canisters. Journal of Chromatography B, Biomedical Applications 1995; 665: 271-279.
14. Lindstrom A, JD Pleil J. Alveolar breath sampling and analysis to assess exposures to methyl tertiary butyl ether (MTBE) during motor vehicle refueling. J Air Waste Manage Assoc 1996; 46: 676-682.
15. Nihlen A, Lof A, Johanson G. Liquid/air partition coefficients of methyl and ethyl i-butyl ethers, t-amyl methyl ether, and i-butyl alcohol. Journal of Exposure Analysis and Environmental Epidemiology 1995; 5: 573-582.
16. Nihlen A, Lof A, G Johanson G. Experimental exposure to methyl tertiary-butyl ether: Toxicokinetics in humans. Toxicol Appl Pharm 1998; 148: 274-280.
17. Rappaport SM. Smoothing of exposure variability at the receptor: implications for health standards. Ann Occup Hyg 1985; 29: 201-214.
18. Rappaport SM, Symanski E, Yager JW, Kupper LL. The relationship between environmental monitoring and biological markers in exposure assessment. Environ Health Perspect 1995; 103 Suppl 3: 49-53.